Ignite Creation Date:
2024-05-06 @ 8:14 AM
Last Modification Date:
2024-10-26 @ 11:58 AM
Study NCT ID:
NCT02698124
Status:
UNKNOWN
Last Update Posted:
2016-03-07
First Post:
2016-02-19
Brief Title:
Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
Sponsor:
Ulsan University Hospital
Organization:
Ulsan University Hospital
Study Overview
Official Title:
Prospective Observation of the indUction Regimen for Acute Non-Promyelocytic Myeloid Leukemia in Elderly Decitabine for Chemotherapy Unfit Korean Acute Myeloid Leukemia AML Patients in Real Practice
Status:
UNKNOWN
Status Verified Date:
2016-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PURPLE-D
Brief Summary:
Prospective multicenter open-lab el observational single arm study of decitabine Subjects will be elderly patients with newly diagnosed treatment-naïve AML who are unfit to receive and not candidate for intensive induction chemotherapy iIC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None